Medication info
Monospin Tablet 80 mg (Telmisartan)

Monospin Tablet 80 mg (Telmisartan)

Prescription medicationTabletOral
Ingredient · strength
Telmisartan›80mg / 1 tablet
Manufacturer / importer
Bionex Co., Ltd.
Appearance
White oval tablet
Packaging
30 tablets/box [10 tablets/PTP×3], 30 tablets/bottle
Approval status
Active

MFDS item code 201603851 · Approved 2016.06.23 · Insurance code 643104750

Summary

Main use
Treatment of essential hypertension and reduction of cardiovascular disease risk
Who takes it
Adults
Adult dose
1. Essential hypertension Adults: Telmisartan 40 mg should be administered orally once daily with water and may be taken with or without food. A dose of 20 mg once daily may be effective in some patients. If necessary, the dose may be increased to 80 mg once daily. When increasing the dose, the maximum blood pressure-lowering effect is reached 4 ∼ 8 weeks after starting treatment. When this medication is coadministered with a thiazide diuretic such as hydrochlorothiazide, an additional blood pressure-lowering effect is observed. 2. Reduction of cardiovascular risk Adults: It is recommended that this medication be administered orally at a dose of 80 mg once daily with water and may be taken with or without food. The risk-reduction effect on cardiovascular morbidity and mortality at doses below 80 mg has not been established. When initiating treatment with this medication to reduce cardiovascular risk, blood pressure monitoring is recommended, and appropriate adjustment of antihypertensive therapy may be required. ○ Patients with hepatic impairment Use with caution in patients with mild ∼ moderate hepatic impairment, and do not exceed 40 mg once daily.

Ingredients

Manufacturer
Bionex Co., Ltd.

Efficacy & effects

Treatment of essential hypertension and reduction of cardiovascular disease risk

  • Essential hypertension
View approved original text

This medication is used to control blood pressure in patients with essential hypertension. It also helps lower the risk of myocardial infarction, stroke, and cardiovascular disease mortality in patients aged 55 and older who are at high risk for cardiovascular disease, such as those with coronary artery disease or stroke, or those with high-risk diabetes. Particularly, it can be administered to patients who cannot tolerate ACE inhibitors, making it effective for the prevention of cardiovascular diseases. It is actively used for hypertension management and maintaining cardiovascular health.

How to take

Adult dose

1. Essential hypertension Adults: Telmisartan 40 mg should be administered orally once daily with water and may be taken with or without food. A dose of 20 mg once daily may be effective in some patients. If necessary, the dose may be increased to 80 mg once daily. When increasing the dose, the maximum blood pressure-lowering effect is reached 4 ∼ 8 weeks after starting treatment. When this medication is coadministered with a thiazide diuretic such as hydrochlorothiazide, an additional blood pressure-lowering effect is observed. 2. Reduction of cardiovascular risk Adults: It is recommended that this medication be administered orally at a dose of 80 mg once daily with water and may be taken with or without food. The risk-reduction effect on cardiovascular morbidity and mortality at doses below 80 mg has not been established. When initiating treatment with this medication to reduce cardiovascular risk, blood pressure monitoring is recommended, and appropriate adjustment of antihypertensive therapy may be required. ○ Patients with hepatic impairment Use with caution in patients with mild ∼ moderate hepatic impairment, and do not exceed 40 mg once daily.

Precautions

This medication can cause severe harm to the fetus and newborn, particularly during pregnancy, so it must be discontinued immediately upon confirmation of pregnancy. It should not be used in patients with allergies to this medication or its ingredients, pregnant or nursing women, patients with severe liver impairment, patients with hereditary angioedema, or patients with diabetes or severe kidney impairment. Caution should be exercised when administering to elderly patients or those with hyperkalemia, liver impairment, or cardiovascular diseases, as there is a risk of myocardial infarction or stroke if blood pressure drops too low. While taking this medication, various adverse reactions such as infections, blood abnormalities, hyperkalemia, hypoglycemia, kidney function deterioration, liver function abnormalities, and allergic reactions may occur, so any abnormal symptoms should be reported to medical personnel immediately. Particularly serious side effects such as angioedema, shock, syncope, interstitial pneumonia, or rhabdomyolysis may occur, so symptoms should be closely monitored. In patients with impaired kidney function, serum potassium and creatinine levels should be regularly monitored, and caution is necessary as hypotension may occur in states of reduced blood volume or sodium. Additionally, interactions may occur when this medication is used in conjunction with other antihypertensive medications, certain diuretics, lithium, non-steroidal anti-inflammatory drugs, etc., so it is essential to consult a doctor or pharmacist. Women who are pregnant or nursing are advised not to take this medication; if it must be taken, breastfeeding should be stopped. Its safety and efficacy in children under 18 years have not been established, so it is not recommended. In case of overdose, symptoms such as hypotension, dizziness, acute renal failure, etc., may occur, requiring immediate medical attention and frequent monitoring of blood pressure and electrolyte levels. This medication should be kept out of the reach of children, maintained in a sealed state until use, and not transferred to other containers.

Side effects

  • Upper respiratory tract infection
  • pharyngitis
  • sinusitis
  • urinary tract infection
  • cystitis
  • sepsis
  • anemia
  • thrombocytopenia
  • eosinophilia
  • hypersensitivity
Show 123 more
  • anaphylactic reaction
  • hyperkalemia
  • hypoglycemia
  • hyponatremia
  • depression
  • insomnia
  • anxiety
  • syncope
  • drowsiness
  • visual disturbances
  • dizziness
  • bradycardia
  • tachycardia
  • hypotension
  • orthostatic hypotension
  • respiratory distress
  • cough
  • interstitial lung disease
  • abdominal pain
  • diarrhea
  • dyspepsia
  • abdominal distension
  • vomiting
  • abdominal discomfort
  • dry mouth
  • taste disturbance
  • liver dysfunction
  • liver damage
  • increased sweating
  • itching
  • rash
  • erythema
  • angioedema
  • drug rash
  • toxic skin rash
  • eczema
  • urticaria
  • myalgia
  • low back pain
  • muscle cramps
  • arthralgia
  • limb pain
  • tendon pain
  • acute renal failure
  • chest pain
  • weakness
  • influenza-like illness
  • increased serum creatinine
  • increased serum uric acid
  • elevated liver enzymes
  • elevated serum creatine kinase
  • decreased hemoglobin
  • weakness
  • hunger
  • cold sweat
  • tremors
  • decreased concentration
  • convulsions
  • altered consciousness
  • facial swelling
  • lip swelling
  • pharyngeal laryngeal swelling
  • tongue swelling
  • laryngeal edema
  • severe hyperkalemia
  • renal failure
  • shock
  • syncope due to hypotension
  • loss of consciousness
  • jaundice
  • respiratory distress
  • blood pressure drop
  • laryngeal edema
  • fever
  • pneumonia
  • myalgia
  • elevated creatine kinase
  • increased serum myoglobin
  • increased urinary myoglobin
  • palpitations
  • fatigue
  • nausea
  • lack of efficacy
  • headache
  • dizziness
  • facial twitching
  • sensory disturbance
  • paralysis
  • hyperventilation
  • pneumonia
  • flushing
  • erectile dysfunction
  • loss of appetite
  • arrhythmia
  • weakness
  • edema
  • decreased libido
  • facial edema
  • rash
  • alopecia
  • conjunctivitis
  • tinnitus
  • petechiae
  • headache
  • dizziness
  • myalgia
  • dermatitis
  • dizziness
  • dyspepsia
  • cough
  • abdominal pain
  • loss of appetite
  • weakness
  • intestinal vascular edema
  • abdominal pain
  • nausea
  • vomiting
  • diarrhea
  • hypotension
  • tachycardia
  • bradycardia
  • dizziness
  • acute renal failure

Not everyone experiences these, and they can vary from person to person.

Storage

This medication may be sensitive to air and moisture, so it should be stored in a tightly closed container. The storage temperature should be maintained at room temperature between 1 degree to 30 degrees. This way, the effectiveness of the medication can be safely preserved.

Appearance and packaging

Appearance

White oval tablet

Package unit

30 tablets/box [10 tablets/PTP×3], 30 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.